Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000794414 | SCV000933819 | uncertain significance | Gastrointestinal stromal tumor; Paragangliomas 3 | 2023-06-29 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 641223). This variant has not been reported in the literature in individuals affected with SDHC-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glycine, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 47 of the SDHC protein (p.Gly47Ala). |
Ambry Genetics | RCV004659205 | SCV005161249 | uncertain significance | Hereditary cancer-predisposing syndrome | 2024-05-12 | criteria provided, single submitter | clinical testing | The p.G47A variant (also known as c.140G>C), located in coding exon 3 of the SDHC gene, results from a G to C substitution at nucleotide position 140. The glycine at codon 47 is replaced by alanine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. |